Optimization of Electronically Monitored Non-Adherence in Highly Adherent Renal Transplant Recipients by Reducing the Dosing Frequency – A Prospective Single-Center Observational Study

References

• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int. 2005;18(10):1121–1133. doi:10.1111/j.1432-2277.2005.00176.x
   PubMed Web of Science ®Google Scholar
• Scheel J, Reber S, Stoessel L, et al. Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation. BMC Nephrol. 2017;18(1):107. doi:10.1186/s12882-017-0517-6
   PubMed Web of Science ®Google Scholar
• Pinsky BW, Takemoto SK, Lentine KL, et al. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9(11):2597–2606. doi:10.1111/j.1600-6143.2009.02798.x
   PubMed Web of Science ®Google Scholar
• De Geest S, Abraham I, Moons P, et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant. 1998;17(9):854–863.
   PubMed Web of Science ®Google Scholar
• Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83(7):858–873. doi:10.1097/01.tp.0000258599.65257.a6
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhou Y, Zhang L, et al. Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: a meta-analysis and systematic review. J Investig Med. 2017;65(7):1049–1056. doi:10.1136/jim-2016-000265
   PubMed Web of Science ®Google Scholar
• Foster BJ, Pai A, Zelikovsky N, et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT). Am J Kidney Dis. 2018;72(1):30–41. doi:10.1053/j.ajkd.2017.12.012
   PubMed Web of Science ®Google Scholar
• Russell CL, Hathaway D, Remy LM, et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: systemCHANGE results of the MAGIC randomized clinical trial. Am J Transplant. 2020;20(1):125–136. doi:10.1111/ajt.15528
   Web of Science ®Google Scholar
• Low JK, Williams A, Manias E, et al. Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrol Dial Transplant. 2014;30(5):752–761.
   Web of Science ®Google Scholar
• Nevins TE, Nickerson PW, Dew MA. Understanding medication nonadherence after kidney transplant. J Am Soc Nephrol. 2017;28(8):2290–2301. doi:10.1681/ASN.2017020216
   PubMed Web of Science ®Google Scholar
• Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–183. doi:10.1177/109019818801500203
   PubMedGoogle Scholar
• Reber S, Morawa E, Stossel L, et al. Prevalence and modifiable determinants of non-adherence in adult kidney transplant recipients in a German sample. Z Psychosom Med Psychother. 2016;62(3):270–283. doi:10.13109/zptm.2016.62.3.270
   PubMed Web of Science ®Google Scholar
• Chisholm-Burns M, Pinsky B, Parker G, et al. Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transplant. 2012;26(5):706–713. doi:10.1111/j.1399-0012.2011.01589.x
   PubMed Web of Science ®Google Scholar
• Griva K, Davenport A, Harrison M, et al. Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake. Ann Behav Med. 2012;44(1):85–93. doi:10.1007/s12160-012-9359-4
   PubMed Web of Science ®Google Scholar
• Schmid-Mohler G, Thut MP, Wuthrich RP, et al. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clin Transplant. 2010;24(2):213–222. doi:10.1111/j.1399-0012.2009.01056.x
   Web of Science ®Google Scholar
• Weng FL, Chandwani S, Kurtyka KM, et al. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. BMC Nephrol. 2013;14:261. doi:10.1186/1471-2369-14-261
   Web of Science ®Google Scholar
• Pabst S, Bertram A, Zimmermann T, et al. Physician reported adherence to immunosuppressants in renal transplant patients: prevalence, agreement, and correlates. J Psychosom Res. 2015;79(5):364–371. doi:10.1016/j.jpsychores.2015.09.001
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–2107. doi:10.1001/archinte.160.14.2101
   PubMed Web of Science ®Google Scholar
• Jindal RM, Neff RT, Abbott KC, et al. Association between depression and nonadherence in recipients of kidney transplants: analysis of the United States renal data system. Transplant Proc. 2009;41(9):3662–3666. doi:10.1016/j.transproceed.2009.06.187
   PubMed Web of Science ®Google Scholar
• Prihodova L, Nagyova I, Rosenberger J, et al. Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study. J Adv Nurs. 2014;70(12):2871–2883. doi:10.1111/jan.12447
   PubMed Web of Science ®Google Scholar
• Denhaerynck K, Steiger J, Bock A, et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant. 2007;7(1):108–116. doi:10.1111/j.1600-6143.2006.01611.x
   PubMed Web of Science ®Google Scholar
• Liu J, Liu S, Yan J, et al. Adherence to immunosuppressive medication in renal transplant recipients from follow-up outpatient in China: association of 2 different measurement methods. Clin Ther. 2015;37(11):2572–2580. doi:10.1016/j.clinthera.2015.09.014
   Web of Science ®Google Scholar
• Russell CL, Ashbaugh C, Peace L, et al. Time-in-a-bottle (TIAB): a longitudinal, correlational study of patterns, potential predictors, and outcomes of immunosuppressive medication adherence in adult kidney transplant recipients. Clin Transplant. 2013;27(5):E580–590. doi:10.1111/ctr.12203
   Web of Science ®Google Scholar
• Calia R, Lai C, Aceto P, et al. Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study. Physiol Behav. 2015;142:152–154. doi:10.1016/j.physbeh.2015.02.018
   PubMed Web of Science ®Google Scholar
• Silva AN, Moratelli L, Tavares PL, et al. Self-efficacy beliefs, locus of control, religiosity and non-adherence to immunosuppressive medications in kidney transplant patients. Nephrology (Carlton). 2016;21(11):938–943. doi:10.1111/nep.12695
   PubMed Web of Science ®Google Scholar
• Calia R, Lai C, Aceto P, et al. Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. Ren Fail. 2015;37(4):678–680. doi:10.3109/0886022X.2015.1010989
   PubMed Web of Science ®Google Scholar
• Scheel JF, Schieber K, Reber S, et al. Psychosocial variables associated with immunosuppressive medication non-adherence after renal transplantation. Front Psychiatry. 2018;9:23. doi:10.3389/fpsyt.2018.00023
   PubMed Web of Science ®Google Scholar
• Chisholm-Burns MA, Spivey CA, Wilks SE. Social support and immunosuppressant therapy adherence among adult renal transplant recipients. Clin Transplant. 2010;24(3):312–320. doi:10.1111/j.1399-0012.2009.01060.x
   PubMed Web of Science ®Google Scholar
• Kuypers DR, Peeters PC, Sennesael JJ, et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation. 2013;95(2):333–340. doi:10.1097/TP.0b013e3182725532
   PubMed Web of Science ®Google Scholar
• Weng FL, Israni AK, Joffe MM, et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005;16(6):1839–1848. doi:10.1681/ASN.2004121059
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Hama K, Katayama H, et al. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients. Transplant Proc. 2012;44(1):124–127. doi:10.1016/j.transproceed.2011.11.051
   Web of Science ®Google Scholar
• Hatakeyama S, Fujita T, Yoneyama T, et al. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients. Transplant Proc. 2012;44(1):121–123. doi:10.1016/j.transproceed.2011.11.022
   Web of Science ®Google Scholar
• Guirado L, Cantarell C, Franco A, et al. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. Am J Transplant. 2011;11(9):1965–1971. doi:10.1111/j.1600-6143.2011.03571.x
   PubMed Web of Science ®Google Scholar
• Denhaerynck K, Schmid-Mohler G, Kiss A, et al. Differences in medication adherence between living and deceased donor kidney transplant patients. Int J Organ Transplant Med. 2014;5(1):7–14.
   Google Scholar
• Massey EK, Tielen M, Laging M, et al. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. J Psychosom Res. 2013;75(3):229–234. doi:10.1016/j.jpsychores.2013.07.006
   PubMed Web of Science ®Google Scholar
• Foster BJ, Pai ALH. Adherence in adolescent and young adult kidney transplant recipients. Open Urol Nephrol J. 2014;7:133–143. doi:10.2174/1874303X01407010133
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Reese PP, Bloom RD, Trofe-Clark J, et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. Am J Kidney Dis. 2017;69(3):400–409. doi:10.1053/j.ajkd.2016.10.017
   PubMed Web of Science ®Google Scholar
• Russell CL, Moore S, Hathaway D, et al. MAGIC study: aims, design and methods using systemCHANGE to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrol. 2016;17(1):84. doi:10.1186/s12882-016-0285-8
   Web of Science ®Google Scholar
• Schäfer-Keller P, Steiger J, Bock A, et al. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8(3):616–626. doi:10.1111/j.1600-6143.2007.02127.x
   PubMed Web of Science ®Google Scholar
• Denhaerynck K, Schafer-Keller P, Young J, et al. Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol. 2008;8:5. doi:10.1186/1471-2288-8-5
   Web of Science ®Google Scholar
• De Bleser L, De Geest S, Vandenbroeck S, et al. How accurate are electronic monitoring devices? A laboratory study testing two devices to measure medication adherence. Sensors (Basel). 2010;10:1652–1660. doi:10.3390/s100301652
   Web of Science ®Google Scholar
• Deschamps AE, Van Wijngaerden E, Denhaerynck K, et al. Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr. 2006;43(2):247–248. doi:10.1097/01.qai.0000246034.86135.89
   PubMed Web of Science ®Google Scholar
• Riekert KA, Rand CS. Electronic monitoring of medication adherence: when is high-tech best? J Clin Psychol Med Settings. 2002;8(1):25–34. doi:10.1023/A:1014131928789
   Web of Science ®Google Scholar
• Dobbels F, Berben L, De Geest S, et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation. 2010;90(2):205–219. doi:10.1097/TP.0b013e3181e346cd
   PubMed Web of Science ®Google Scholar
• Lieb M, Hepp T, Schiffer M, et al. Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study. BMC Nephrol. 2020;21(1):114. doi:10.1186/s12882-020-01781-1
   Web of Science ®Google Scholar
• De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30–35. doi:10.7326/M18-0543
   PubMed Web of Science ®Google Scholar
• Löwe B, Spitzer R, Zipfel S, et al. Gesundheitsfragebogen für Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Fragebögen, Schablonen. Karlsruhe: Pfizer; 2002.
   Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
   PubMed Web of Science ®Google Scholar
• Fydrich T, Geyer M, Hessel A, et al. Fragebogen zur Sozialen Unterstützung (F-SozU): normierung an einer repräsentativen Stichprobe. Diagnostica. 1999;45:212–216. doi:10.1026//0012-1924.45.4.212
   Web of Science ®Google Scholar
• Angermeyer C, Kilian R, Matschinger H. Deutschsprachige Version der WHO Instrumente zur Erfassung von Lebensqualität WHOQOL-100 und WHOQOL-BREFM. Z Med Psychol. 2002;11:44–48.
   Google Scholar
• Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J, Wright S, Johston M, editors. Measures in Health Psychology: A User’s Portfolio. Causal and Control Beliefs, Windsor. England: Nfer-Nelson; 1995:35–37.
   Google Scholar
• Schwarzer R, Jerusalem M. Skalen zur Erfassung von Lehrer- und Schülermerkmalen: Dokumentation der psychometrischen Verfahren im Rahmen der Wissenschaftlichen Begleitung des Modellversuchs Selbstwirksame Schulen. Berlin: Freie Universität Berlin; 1999.
   Google Scholar
• Steffanowski M, Oppl J, Meyerberg J, et al. Psychometrische Überprüfung einer deutschsprachigen Version des Relationship Scales Questionnaire (RSQ). In: Bassler M, editor. Störungsspezifische Therapieansätze - Konzepte und Ergebnisse, Gießen. 2001.
   Google Scholar
• Griffin DW, Bartholomew K. The metaphysics of measurement: the case of adult attachment. In: Bartholomew K, Perlman D, editors. Attachment Processes in Adulthood. Advances in Personal Relationships. Jessica Kingsley; 1994:17.
   Google Scholar
• Goetzmann L, Klaghofer R, Spindler A, et al. Die “Medikamenten-Erfahrungs-Skala für Immunsuppressiva” (MESI) - erste Ergebnisse zu einem neuen Screeninginstrument in der Transplantationsmedizin. [The “Medication experience scale for immunosuppressants” (MESI): initial results for a new screening instrument in transplant medicine]. Psychother Psychosom Med Psychol. 2006;56(2):49–55. doi:10.1055/s-2005-867060
   Web of Science ®Google Scholar
• Klaghofer R, Sarac N, Schwegler K, et al. Fragebogen zur psychischen verabeitung einer organtransplantation: deutsche validierung des transplant effects questionnaire (TxEQ) [Questionnaire on emotional response after organ transplantation: German validation of the transplant effect questionnaire (TxEQ-D)]. Z Psychosom Med Psychother. 2008;54(2):174–188. doi:10.13109/zptm.2008.54.2.174
   Web of Science ®Google Scholar
• Ziegelmann JP, Griva K, Hankins M, et al. The transplant effects questionnaire (TxEQ): the development of a questionnaire for assessing the multidimensional outcome of organ transplantation - example of end stage renal disease (ESRD). Br J Health Psychol. 2002;7(Part 4):393–408. doi:10.1348/135910702320645381
   Web of Science ®Google Scholar
• Mahler C, Jank S, Hermann K, et al. Psychometric properties of a German version of the “Satisfaction with information about medicines scale” (SIMS-D). Value Health. 2009;12(8):1176–1179. doi:10.1111/j.1524-4733.2009.00575.x
   Web of Science ®Google Scholar
• Horne R, Hankins M, Jenkins R. The satisfaction with information about medicines scale (SIMS): a new measurement tool for audit and research. Qual Health Care. 2001;10(3):135–140. doi:10.1136/qhc.0100135
   PubMedGoogle Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24. doi:10.1080/08870449908407311
   Web of Science ®Google Scholar
• Mahler C, Hermann K, Horne R, et al. Patients’ beliefs about medicines in a primary care setting in Germany. J Eval Clin Pract. 2012;18(2):409–413. doi:10.1111/j.1365-2753.2010.01589.x
   Web of Science ®Google Scholar
• Bova CA, Fennie KP, Knafl GJ, et al. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9(1):103–110. doi:10.1007/s10461-005-1685-0
   PubMed Web of Science ®Google Scholar
• Belaiche S, Decaudin B, Dharancy S, et al. Factors relevant to medication non-adherence in kidney transplant: a systematic review. Int J Clin Pharm. 2017;39(3):582–593. doi:10.1007/s11096-017-0436-4
   PubMed Web of Science ®Google Scholar
• Leino AD, King EC, Jiang W, et al. Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values. Am J Transplant. 2019;19(5):1410–1420. doi:10.1111/ajt.15199
   Web of Science ®Google Scholar
• Beckebaum S, Iacob S, Sweid D, et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24(7):666–675. doi:10.1111/j.1432-2277.2011.01254.x
   PubMed Web of Science ®Google Scholar
• Doesch AO, Mueller S, Akyol C, et al. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Drug Des Devel Ther. 2013;7:1253–1258. doi:10.2147/DDDT.S52820
   PubMed Web of Science ®Google Scholar
• Tran D, Vallee M, Collette S, et al. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature. Exp Clin Transplant. 2014;12(4):323–327. doi:10.6002/ect.2013.0165
   PubMed Web of Science ®Google Scholar
• Considine A, Tredger JM, Heneghan M, et al. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts. Liver Transpl. 2015;21(1):29–37. doi:10.1002/lt.24022
   Web of Science ®Google Scholar
• Gorevski E, Succop P, Sachdeva J, et al. Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population? Patient Prefer Adherence. 2013;7:301–307. doi:10.2147/PPA.S34945
   PubMed Web of Science ®Google Scholar
• Dew MA, Posluszny DM, DiMartini AF, et al. Posttransplant medical adherence: what have we learned and can we do better? Curr Transplant Rep. 2018;5(2):174–188. doi:10.1007/s40472-018-0195-8
   PubMedGoogle Scholar
• Ladin K, Daniels A, Osani M, et al. Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis. Transplant Rev (Orlando). 2018;32(1):16–28. doi:10.1016/j.trre.2017.04.001
   PubMedGoogle Scholar
• Berben L, Dobbels F, Engberg S, et al. An ecological perspective on medication adherence. West J Nurs Res. 2012;34(5):635–653. doi:10.1177/0193945911434518
   PubMed Web of Science ®Google Scholar
• Feehan M, Morrison MA, Tak C, et al. Factors predicting self-reported medication low adherence in a large sample of adults in the US general population: a cross-sectional study. BMJ Open. 2017;7(6):e014435. doi:10.1136/bmjopen-2016-014435
   PubMed Web of Science ®Google Scholar